Edwin Wagena

Company: Sutura Therapeutics

Job title: Chief Executive Officer

Seminars:

A Transformational Drug Delivery Technology: Using Stabilised PepPeptides to Deliver Proteins and RNA-Targeting Payloads to the Cell Interior 11:30 am

Improving cellular penetration and stability of biomolecular medicines. Enabling the delivery of diverse payloads in specific tissues in the body, allowing for a disease-agnostic approach. Varying the number and placement of staples on peptides to determine the most effective conformation in combination with different payloads Read more

day: Conference Day 1